Global Botulinum Toxin & HA Dermal Filler Supply, Demand and Key Producers, 2024-2030

Global Botulinum Toxin & HA Dermal Filler Supply, Demand and Key Producers, 2024-2030

Page: 163

Published Date: 15 Sep 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

HA Dermal Filler are gel-like substances injected under the skin to restore lost volume, smooth and soften wrinkles or enhance facial contours. HA Dermal Filler have developed rapidly and are getting closer and closer to "perfect" products: long-lasting but non-permanent, high tolerability, exquisite and natural cosmetic effects, and reversible in the event of adverse surgical outcomes. HA Dermal Filler help to diminish facial lines and restore volume and fullness in the face. HA Dermal Filler can be used to: plump thin lips, enhance shallow contours, soften facial creases and wrinkles and improve the appearance of recessed scars. HA Dermal Filler can be very helpful in those with early signs of aging, or as a value-added part of facial rejuvenation surgery.

Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.

The global Botulinum Toxin & HA Dermal Filler market size is expected to reach $ 28320 million by 2030, rising at a market growth of 10.0% CAGR during the forecast period (2024-2030).

The HA Dermal Filler and botulinum toxin market is driven by the growing demand for non-invasive cosmetic procedures. As people seek quicker, safer, and more affordable ways to enhance their appearance, the demand for products like botulinum toxin (Botox) and HA Dermal Filler has surged. This trend is further fueled by increasing social media influence, rising disposable incomes, and the aging population looking for anti-aging treatments. The availability of minimally invasive options with shorter recovery times compared to surgical procedures also appeals to a broad demographic, further pushing market growth.

However, the market faces several challenges. One of the key issues is the risk of side effects and complications from improper administration, which can lead to negative public perception. Additionally, the regulatory landscape is stringent, with healthcare authorities enforcing strict safety and efficacy standards. High costs of premium products, as well as the need for repeated treatments to maintain results, may also deter some consumers, limiting the market's potential growth.

Global key players of HA Dermal Filler and botulinum toxin include AbbVie, Galderma, LG Life Sciences, etc. The top five players hold a share about 78%. Americas is the largest market, has a share about 58%, followed by Europe and Asia-Pacific, with share 20% and 18%, separately.

This report studies the global Botulinum Toxin & HA Dermal Filler production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Botulinum Toxin & HA Dermal Filler and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Botulinum Toxin & HA Dermal Filler that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Botulinum Toxin & HA Dermal Filler total production and demand, 2019-2030, (K Units)
Global Botulinum Toxin & HA Dermal Filler total production value, 2019-2030, (USD Million)
Global Botulinum Toxin & HA Dermal Filler production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global Botulinum Toxin & HA Dermal Filler consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Botulinum Toxin & HA Dermal Filler domestic production, consumption, key domestic manufacturers and share
Global Botulinum Toxin & HA Dermal Filler production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Botulinum Toxin & HA Dermal Filler production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Botulinum Toxin & HA Dermal Filler production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global Botulinum Toxin & HA Dermal Filler market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Galderma, LG Life Sciences, Merz, Medytox, Hugel, Croma-Pharma, Beijing IMEIK, Bloomage Bio, Elravie (Humedix), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Botulinum Toxin & HA Dermal Filler market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Botulinum Toxin & HA Dermal Filler Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Botulinum Toxin & HA Dermal Filler Market, Segmentation by Type:
Botulinum Toxin
HA Dermal Filler

Global Botulinum Toxin & HA Dermal Filler Market, Segmentation by Application:
Medical
Cosmetics

Companies Profiled:
AbbVie
Galderma
LG Life Sciences
Merz
Medytox
Hugel
Croma-Pharma
Beijing IMEIK
Bloomage Bio
Elravie (Humedix)
Cleviel (Pharma Research Products)
Haohai Biological
Teoxane
Sinclair
Suneva Medical
CG Bio
SciVision Biotech
Prollenium
Bohus BioTech
Caregen
Ipsen
LIBP
US World Meds
Daewoong
JETEMA

Key Questions Answered:
1. How big is the global Botulinum Toxin & HA Dermal Filler market?
2. What is the demand of the global Botulinum Toxin & HA Dermal Filler market?
3. What is the year over year growth of the global Botulinum Toxin & HA Dermal Filler market?
4. What is the production and production value of the global Botulinum Toxin & HA Dermal Filler market?
5. Who are the key producers in the global Botulinum Toxin & HA Dermal Filler market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Botulinum Toxin & HA Dermal Filler Introduction
1.2 World Botulinum Toxin & HA Dermal Filler Supply & Forecast
1.2.1 World Botulinum Toxin & HA Dermal Filler Production Value (2019 & 2023 & 2030)
1.2.2 World Botulinum Toxin & HA Dermal Filler Production (2019-2030)
1.2.3 World Botulinum Toxin & HA Dermal Filler Pricing Trends (2019-2030)
1.3 World Botulinum Toxin & HA Dermal Filler Production by Region (Based on Production Site)
1.3.1 World Botulinum Toxin & HA Dermal Filler Production Value by Region (2019-2030)
1.3.2 World Botulinum Toxin & HA Dermal Filler Production by Region (2019-2030)
1.3.3 World Botulinum Toxin & HA Dermal Filler Average Price by Region (2019-2030)
1.3.4 North America Botulinum Toxin & HA Dermal Filler Production (2019-2030)
1.3.5 Europe Botulinum Toxin & HA Dermal Filler Production (2019-2030)
1.3.6 China Botulinum Toxin & HA Dermal Filler Production (2019-2030)
1.3.7 Japan Botulinum Toxin & HA Dermal Filler Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Botulinum Toxin & HA Dermal Filler Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Botulinum Toxin & HA Dermal Filler Major Market Trends

2 Demand Summary
2.1 World Botulinum Toxin & HA Dermal Filler Demand (2019-2030)
2.2 World Botulinum Toxin & HA Dermal Filler Consumption by Region
2.2.1 World Botulinum Toxin & HA Dermal Filler Consumption by Region (2019-2024)
2.2.2 World Botulinum Toxin & HA Dermal Filler Consumption Forecast by Region (2025-2030)
2.3 United States Botulinum Toxin & HA Dermal Filler Consumption (2019-2030)
2.4 China Botulinum Toxin & HA Dermal Filler Consumption (2019-2030)
2.5 Europe Botulinum Toxin & HA Dermal Filler Consumption (2019-2030)
2.6 Japan Botulinum Toxin & HA Dermal Filler Consumption (2019-2030)
2.7 South Korea Botulinum Toxin & HA Dermal Filler Consumption (2019-2030)
2.8 ASEAN Botulinum Toxin & HA Dermal Filler Consumption (2019-2030)
2.9 India Botulinum Toxin & HA Dermal Filler Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
3.1 World Botulinum Toxin & HA Dermal Filler Production Value by Manufacturer (2019-2024)
3.2 World Botulinum Toxin & HA Dermal Filler Production by Manufacturer (2019-2024)
3.3 World Botulinum Toxin & HA Dermal Filler Average Price by Manufacturer (2019-2024)
3.4 Botulinum Toxin & HA Dermal Filler Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Botulinum Toxin & HA Dermal Filler Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Botulinum Toxin & HA Dermal Filler in 2023
3.5.3 Global Concentration Ratios (CR8) for Botulinum Toxin & HA Dermal Filler in 2023
3.6 Botulinum Toxin & HA Dermal Filler Market: Overall Company Footprint Analysis
3.6.1 Botulinum Toxin & HA Dermal Filler Market: Region Footprint
3.6.2 Botulinum Toxin & HA Dermal Filler Market: Company Product Type Footprint
3.6.3 Botulinum Toxin & HA Dermal Filler Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Botulinum Toxin & HA Dermal Filler Production Value Comparison
4.1.1 United States VS China: Botulinum Toxin & HA Dermal Filler Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Botulinum Toxin & HA Dermal Filler Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Botulinum Toxin & HA Dermal Filler Production Comparison
4.2.1 United States VS China: Botulinum Toxin & HA Dermal Filler Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Botulinum Toxin & HA Dermal Filler Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Botulinum Toxin & HA Dermal Filler Consumption Comparison
4.3.1 United States VS China: Botulinum Toxin & HA Dermal Filler Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Botulinum Toxin & HA Dermal Filler Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Botulinum Toxin & HA Dermal Filler Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Botulinum Toxin & HA Dermal Filler Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Value (2019-2024)
4.4.3 United States Based Manufacturers Botulinum Toxin & HA Dermal Filler Production (2019-2024)
4.5 China Based Botulinum Toxin & HA Dermal Filler Manufacturers and Market Share
4.5.1 China Based Botulinum Toxin & HA Dermal Filler Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Value (2019-2024)
4.5.3 China Based Manufacturers Botulinum Toxin & HA Dermal Filler Production (2019-2024)
4.6 Rest of World Based Botulinum Toxin & HA Dermal Filler Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Botulinum Toxin & HA Dermal Filler Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Botulinum Toxin & HA Dermal Filler Production (2019-2024)

5 Market Analysis by Type
5.1 World Botulinum Toxin & HA Dermal Filler Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Botulinum Toxin
5.2.2 HA Dermal Filler
5.3 Market Segment by Type
5.3.1 World Botulinum Toxin & HA Dermal Filler Production by Type (2019-2030)
5.3.2 World Botulinum Toxin & HA Dermal Filler Production Value by Type (2019-2030)
5.3.3 World Botulinum Toxin & HA Dermal Filler Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Botulinum Toxin & HA Dermal Filler Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Medical
6.2.2 Cosmetics
6.3 Market Segment by Application
6.3.1 World Botulinum Toxin & HA Dermal Filler Production by Application (2019-2030)
6.3.2 World Botulinum Toxin & HA Dermal Filler Production Value by Application (2019-2030)
6.3.3 World Botulinum Toxin & HA Dermal Filler Average Price by Application (2019-2030)

7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Details
7.1.2 AbbVie Major Business
7.1.3 AbbVie Botulinum Toxin & HA Dermal Filler Product and Services
7.1.4 AbbVie Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 AbbVie Recent Developments/Updates
7.1.6 AbbVie Competitive Strengths & Weaknesses
7.2 Galderma
7.2.1 Galderma Details
7.2.2 Galderma Major Business
7.2.3 Galderma Botulinum Toxin & HA Dermal Filler Product and Services
7.2.4 Galderma Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Galderma Recent Developments/Updates
7.2.6 Galderma Competitive Strengths & Weaknesses
7.3 LG Life Sciences
7.3.1 LG Life Sciences Details
7.3.2 LG Life Sciences Major Business
7.3.3 LG Life Sciences Botulinum Toxin & HA Dermal Filler Product and Services
7.3.4 LG Life Sciences Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 LG Life Sciences Recent Developments/Updates
7.3.6 LG Life Sciences Competitive Strengths & Weaknesses
7.4 Merz
7.4.1 Merz Details
7.4.2 Merz Major Business
7.4.3 Merz Botulinum Toxin & HA Dermal Filler Product and Services
7.4.4 Merz Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Merz Recent Developments/Updates
7.4.6 Merz Competitive Strengths & Weaknesses
7.5 Medytox
7.5.1 Medytox Details
7.5.2 Medytox Major Business
7.5.3 Medytox Botulinum Toxin & HA Dermal Filler Product and Services
7.5.4 Medytox Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Medytox Recent Developments/Updates
7.5.6 Medytox Competitive Strengths & Weaknesses
7.6 Hugel
7.6.1 Hugel Details
7.6.2 Hugel Major Business
7.6.3 Hugel Botulinum Toxin & HA Dermal Filler Product and Services
7.6.4 Hugel Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Hugel Recent Developments/Updates
7.6.6 Hugel Competitive Strengths & Weaknesses
7.7 Croma-Pharma
7.7.1 Croma-Pharma Details
7.7.2 Croma-Pharma Major Business
7.7.3 Croma-Pharma Botulinum Toxin & HA Dermal Filler Product and Services
7.7.4 Croma-Pharma Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Croma-Pharma Recent Developments/Updates
7.7.6 Croma-Pharma Competitive Strengths & Weaknesses
7.8 Beijing IMEIK
7.8.1 Beijing IMEIK Details
7.8.2 Beijing IMEIK Major Business
7.8.3 Beijing IMEIK Botulinum Toxin & HA Dermal Filler Product and Services
7.8.4 Beijing IMEIK Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Beijing IMEIK Recent Developments/Updates
7.8.6 Beijing IMEIK Competitive Strengths & Weaknesses
7.9 Bloomage Bio
7.9.1 Bloomage Bio Details
7.9.2 Bloomage Bio Major Business
7.9.3 Bloomage Bio Botulinum Toxin & HA Dermal Filler Product and Services
7.9.4 Bloomage Bio Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Bloomage Bio Recent Developments/Updates
7.9.6 Bloomage Bio Competitive Strengths & Weaknesses
7.10 Elravie (Humedix)
7.10.1 Elravie (Humedix) Details
7.10.2 Elravie (Humedix) Major Business
7.10.3 Elravie (Humedix) Botulinum Toxin & HA Dermal Filler Product and Services
7.10.4 Elravie (Humedix) Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Elravie (Humedix) Recent Developments/Updates
7.10.6 Elravie (Humedix) Competitive Strengths & Weaknesses
7.11 Cleviel (Pharma Research Products)
7.11.1 Cleviel (Pharma Research Products) Details
7.11.2 Cleviel (Pharma Research Products) Major Business
7.11.3 Cleviel (Pharma Research Products) Botulinum Toxin & HA Dermal Filler Product and Services
7.11.4 Cleviel (Pharma Research Products) Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Cleviel (Pharma Research Products) Recent Developments/Updates
7.11.6 Cleviel (Pharma Research Products) Competitive Strengths & Weaknesses
7.12 Haohai Biological
7.12.1 Haohai Biological Details
7.12.2 Haohai Biological Major Business
7.12.3 Haohai Biological Botulinum Toxin & HA Dermal Filler Product and Services
7.12.4 Haohai Biological Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Haohai Biological Recent Developments/Updates
7.12.6 Haohai Biological Competitive Strengths & Weaknesses
7.13 Teoxane
7.13.1 Teoxane Details
7.13.2 Teoxane Major Business
7.13.3 Teoxane Botulinum Toxin & HA Dermal Filler Product and Services
7.13.4 Teoxane Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Teoxane Recent Developments/Updates
7.13.6 Teoxane Competitive Strengths & Weaknesses
7.14 Sinclair
7.14.1 Sinclair Details
7.14.2 Sinclair Major Business
7.14.3 Sinclair Botulinum Toxin & HA Dermal Filler Product and Services
7.14.4 Sinclair Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Sinclair Recent Developments/Updates
7.14.6 Sinclair Competitive Strengths & Weaknesses
7.15 Suneva Medical
7.15.1 Suneva Medical Details
7.15.2 Suneva Medical Major Business
7.15.3 Suneva Medical Botulinum Toxin & HA Dermal Filler Product and Services
7.15.4 Suneva Medical Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Suneva Medical Recent Developments/Updates
7.15.6 Suneva Medical Competitive Strengths & Weaknesses
7.16 CG Bio
7.16.1 CG Bio Details
7.16.2 CG Bio Major Business
7.16.3 CG Bio Botulinum Toxin & HA Dermal Filler Product and Services
7.16.4 CG Bio Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 CG Bio Recent Developments/Updates
7.16.6 CG Bio Competitive Strengths & Weaknesses
7.17 SciVision Biotech
7.17.1 SciVision Biotech Details
7.17.2 SciVision Biotech Major Business
7.17.3 SciVision Biotech Botulinum Toxin & HA Dermal Filler Product and Services
7.17.4 SciVision Biotech Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 SciVision Biotech Recent Developments/Updates
7.17.6 SciVision Biotech Competitive Strengths & Weaknesses
7.18 Prollenium
7.18.1 Prollenium Details
7.18.2 Prollenium Major Business
7.18.3 Prollenium Botulinum Toxin & HA Dermal Filler Product and Services
7.18.4 Prollenium Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.18.5 Prollenium Recent Developments/Updates
7.18.6 Prollenium Competitive Strengths & Weaknesses
7.19 Bohus BioTech
7.19.1 Bohus BioTech Details
7.19.2 Bohus BioTech Major Business
7.19.3 Bohus BioTech Botulinum Toxin & HA Dermal Filler Product and Services
7.19.4 Bohus BioTech Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.19.5 Bohus BioTech Recent Developments/Updates
7.19.6 Bohus BioTech Competitive Strengths & Weaknesses
7.20 Caregen
7.20.1 Caregen Details
7.20.2 Caregen Major Business
7.20.3 Caregen Botulinum Toxin & HA Dermal Filler Product and Services
7.20.4 Caregen Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.20.5 Caregen Recent Developments/Updates
7.20.6 Caregen Competitive Strengths & Weaknesses
7.21 Ipsen
7.21.1 Ipsen Details
7.21.2 Ipsen Major Business
7.21.3 Ipsen Botulinum Toxin & HA Dermal Filler Product and Services
7.21.4 Ipsen Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.21.5 Ipsen Recent Developments/Updates
7.21.6 Ipsen Competitive Strengths & Weaknesses
7.22 LIBP
7.22.1 LIBP Details
7.22.2 LIBP Major Business
7.22.3 LIBP Botulinum Toxin & HA Dermal Filler Product and Services
7.22.4 LIBP Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.22.5 LIBP Recent Developments/Updates
7.22.6 LIBP Competitive Strengths & Weaknesses
7.23 US World Meds
7.23.1 US World Meds Details
7.23.2 US World Meds Major Business
7.23.3 US World Meds Botulinum Toxin & HA Dermal Filler Product and Services
7.23.4 US World Meds Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.23.5 US World Meds Recent Developments/Updates
7.23.6 US World Meds Competitive Strengths & Weaknesses
7.24 Daewoong
7.24.1 Daewoong Details
7.24.2 Daewoong Major Business
7.24.3 Daewoong Botulinum Toxin & HA Dermal Filler Product and Services
7.24.4 Daewoong Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.24.5 Daewoong Recent Developments/Updates
7.24.6 Daewoong Competitive Strengths & Weaknesses
7.25 JETEMA
7.25.1 JETEMA Details
7.25.2 JETEMA Major Business
7.25.3 JETEMA Botulinum Toxin & HA Dermal Filler Product and Services
7.25.4 JETEMA Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.25.5 JETEMA Recent Developments/Updates
7.25.6 JETEMA Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Botulinum Toxin & HA Dermal Filler Industry Chain
8.2 Botulinum Toxin & HA Dermal Filler Upstream Analysis
8.2.1 Botulinum Toxin & HA Dermal Filler Core Raw Materials
8.2.2 Main Manufacturers of Botulinum Toxin & HA Dermal Filler Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Botulinum Toxin & HA Dermal Filler Production Mode
8.6 Botulinum Toxin & HA Dermal Filler Procurement Model
8.7 Botulinum Toxin & HA Dermal Filler Industry Sales Model and Sales Channels
8.7.1 Botulinum Toxin & HA Dermal Filler Sales Model
8.7.2 Botulinum Toxin & HA Dermal Filler Typical Distributors

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Botulinum Toxin & HA Dermal Filler Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Botulinum Toxin & HA Dermal Filler Production Value by Region (2019-2024) & (USD Million)
Table 3. World Botulinum Toxin & HA Dermal Filler Production Value by Region (2025-2030) & (USD Million)
Table 4. World Botulinum Toxin & HA Dermal Filler Production Value Market Share by Region (2019-2024)
Table 5. World Botulinum Toxin & HA Dermal Filler Production Value Market Share by Region (2025-2030)
Table 6. World Botulinum Toxin & HA Dermal Filler Production by Region (2019-2024) & (K Units)
Table 7. World Botulinum Toxin & HA Dermal Filler Production by Region (2025-2030) & (K Units)
Table 8. World Botulinum Toxin & HA Dermal Filler Production Market Share by Region (2019-2024)
Table 9. World Botulinum Toxin & HA Dermal Filler Production Market Share by Region (2025-2030)
Table 10. World Botulinum Toxin & HA Dermal Filler Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Botulinum Toxin & HA Dermal Filler Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Botulinum Toxin & HA Dermal Filler Major Market Trends
Table 13. World Botulinum Toxin & HA Dermal Filler Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Botulinum Toxin & HA Dermal Filler Consumption by Region (2019-2024) & (K Units)
Table 15. World Botulinum Toxin & HA Dermal Filler Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Botulinum Toxin & HA Dermal Filler Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Botulinum Toxin & HA Dermal Filler Producers in 2023
Table 18. World Botulinum Toxin & HA Dermal Filler Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Botulinum Toxin & HA Dermal Filler Producers in 2023
Table 20. World Botulinum Toxin & HA Dermal Filler Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Botulinum Toxin & HA Dermal Filler Company Evaluation Quadrant
Table 22. World Botulinum Toxin & HA Dermal Filler Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Botulinum Toxin & HA Dermal Filler Production Site of Key Manufacturer
Table 24. Botulinum Toxin & HA Dermal Filler Market: Company Product Type Footprint
Table 25. Botulinum Toxin & HA Dermal Filler Market: Company Product Application Footprint
Table 26. Botulinum Toxin & HA Dermal Filler Competitive Factors
Table 27. Botulinum Toxin & HA Dermal Filler New Entrant and Capacity Expansion Plans
Table 28. Botulinum Toxin & HA Dermal Filler Mergers & Acquisitions Activity
Table 29. United States VS China Botulinum Toxin & HA Dermal Filler Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Botulinum Toxin & HA Dermal Filler Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Botulinum Toxin & HA Dermal Filler Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Botulinum Toxin & HA Dermal Filler Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Botulinum Toxin & HA Dermal Filler Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Market Share (2019-2024)
Table 37. China Based Botulinum Toxin & HA Dermal Filler Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Botulinum Toxin & HA Dermal Filler Production, (2019-2024) & (K Units)
Table 41. China Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Market Share (2019-2024)
Table 42. Rest of World Based Botulinum Toxin & HA Dermal Filler Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Botulinum Toxin & HA Dermal Filler Production, (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Market Share (2019-2024)
Table 47. World Botulinum Toxin & HA Dermal Filler Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Botulinum Toxin & HA Dermal Filler Production by Type (2019-2024) & (K Units)
Table 49. World Botulinum Toxin & HA Dermal Filler Production by Type (2025-2030) & (K Units)
Table 50. World Botulinum Toxin & HA Dermal Filler Production Value by Type (2019-2024) & (USD Million)
Table 51. World Botulinum Toxin & HA Dermal Filler Production Value by Type (2025-2030) & (USD Million)
Table 52. World Botulinum Toxin & HA Dermal Filler Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Botulinum Toxin & HA Dermal Filler Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Botulinum Toxin & HA Dermal Filler Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Botulinum Toxin & HA Dermal Filler Production by Application (2019-2024) & (K Units)
Table 56. World Botulinum Toxin & HA Dermal Filler Production by Application (2025-2030) & (K Units)
Table 57. World Botulinum Toxin & HA Dermal Filler Production Value by Application (2019-2024) & (USD Million)
Table 58. World Botulinum Toxin & HA Dermal Filler Production Value by Application (2025-2030) & (USD Million)
Table 59. World Botulinum Toxin & HA Dermal Filler Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Botulinum Toxin & HA Dermal Filler Average Price by Application (2025-2030) & (US$/Unit)
Table 61. AbbVie Basic Information, Manufacturing Base and Competitors
Table 62. AbbVie Major Business
Table 63. AbbVie Botulinum Toxin & HA Dermal Filler Product and Services
Table 64. AbbVie Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. AbbVie Recent Developments/Updates
Table 66. AbbVie Competitive Strengths & Weaknesses
Table 67. Galderma Basic Information, Manufacturing Base and Competitors
Table 68. Galderma Major Business
Table 69. Galderma Botulinum Toxin & HA Dermal Filler Product and Services
Table 70. Galderma Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Galderma Recent Developments/Updates
Table 72. Galderma Competitive Strengths & Weaknesses
Table 73. LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 74. LG Life Sciences Major Business
Table 75. LG Life Sciences Botulinum Toxin & HA Dermal Filler Product and Services
Table 76. LG Life Sciences Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. LG Life Sciences Recent Developments/Updates
Table 78. LG Life Sciences Competitive Strengths & Weaknesses
Table 79. Merz Basic Information, Manufacturing Base and Competitors
Table 80. Merz Major Business
Table 81. Merz Botulinum Toxin & HA Dermal Filler Product and Services
Table 82. Merz Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Merz Recent Developments/Updates
Table 84. Merz Competitive Strengths & Weaknesses
Table 85. Medytox Basic Information, Manufacturing Base and Competitors
Table 86. Medytox Major Business
Table 87. Medytox Botulinum Toxin & HA Dermal Filler Product and Services
Table 88. Medytox Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Medytox Recent Developments/Updates
Table 90. Medytox Competitive Strengths & Weaknesses
Table 91. Hugel Basic Information, Manufacturing Base and Competitors
Table 92. Hugel Major Business
Table 93. Hugel Botulinum Toxin & HA Dermal Filler Product and Services
Table 94. Hugel Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Hugel Recent Developments/Updates
Table 96. Hugel Competitive Strengths & Weaknesses
Table 97. Croma-Pharma Basic Information, Manufacturing Base and Competitors
Table 98. Croma-Pharma Major Business
Table 99. Croma-Pharma Botulinum Toxin & HA Dermal Filler Product and Services
Table 100. Croma-Pharma Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Croma-Pharma Recent Developments/Updates
Table 102. Croma-Pharma Competitive Strengths & Weaknesses
Table 103. Beijing IMEIK Basic Information, Manufacturing Base and Competitors
Table 104. Beijing IMEIK Major Business
Table 105. Beijing IMEIK Botulinum Toxin & HA Dermal Filler Product and Services
Table 106. Beijing IMEIK Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Beijing IMEIK Recent Developments/Updates
Table 108. Beijing IMEIK Competitive Strengths & Weaknesses
Table 109. Bloomage Bio Basic Information, Manufacturing Base and Competitors
Table 110. Bloomage Bio Major Business
Table 111. Bloomage Bio Botulinum Toxin & HA Dermal Filler Product and Services
Table 112. Bloomage Bio Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Bloomage Bio Recent Developments/Updates
Table 114. Bloomage Bio Competitive Strengths & Weaknesses
Table 115. Elravie (Humedix) Basic Information, Manufacturing Base and Competitors
Table 116. Elravie (Humedix) Major Business
Table 117. Elravie (Humedix) Botulinum Toxin & HA Dermal Filler Product and Services
Table 118. Elravie (Humedix) Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Elravie (Humedix) Recent Developments/Updates
Table 120. Elravie (Humedix) Competitive Strengths & Weaknesses
Table 121. Cleviel (Pharma Research Products) Basic Information, Manufacturing Base and Competitors
Table 122. Cleviel (Pharma Research Products) Major Business
Table 123. Cleviel (Pharma Research Products) Botulinum Toxin & HA Dermal Filler Product and Services
Table 124. Cleviel (Pharma Research Products) Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Cleviel (Pharma Research Products) Recent Developments/Updates
Table 126. Cleviel (Pharma Research Products) Competitive Strengths & Weaknesses
Table 127. Haohai Biological Basic Information, Manufacturing Base and Competitors
Table 128. Haohai Biological Major Business
Table 129. Haohai Biological Botulinum Toxin & HA Dermal Filler Product and Services
Table 130. Haohai Biological Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Haohai Biological Recent Developments/Updates
Table 132. Haohai Biological Competitive Strengths & Weaknesses
Table 133. Teoxane Basic Information, Manufacturing Base and Competitors
Table 134. Teoxane Major Business
Table 135. Teoxane Botulinum Toxin & HA Dermal Filler Product and Services
Table 136. Teoxane Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Teoxane Recent Developments/Updates
Table 138. Teoxane Competitive Strengths & Weaknesses
Table 139. Sinclair Basic Information, Manufacturing Base and Competitors
Table 140. Sinclair Major Business
Table 141. Sinclair Botulinum Toxin & HA Dermal Filler Product and Services
Table 142. Sinclair Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Sinclair Recent Developments/Updates
Table 144. Sinclair Competitive Strengths & Weaknesses
Table 145. Suneva Medical Basic Information, Manufacturing Base and Competitors
Table 146. Suneva Medical Major Business
Table 147. Suneva Medical Botulinum Toxin & HA Dermal Filler Product and Services
Table 148. Suneva Medical Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Suneva Medical Recent Developments/Updates
Table 150. Suneva Medical Competitive Strengths & Weaknesses
Table 151. CG Bio Basic Information, Manufacturing Base and Competitors
Table 152. CG Bio Major Business
Table 153. CG Bio Botulinum Toxin & HA Dermal Filler Product and Services
Table 154. CG Bio Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 155. CG Bio Recent Developments/Updates
Table 156. CG Bio Competitive Strengths & Weaknesses
Table 157. SciVision Biotech Basic Information, Manufacturing Base and Competitors
Table 158. SciVision Biotech Major Business
Table 159. SciVision Biotech Botulinum Toxin & HA Dermal Filler Product and Services
Table 160. SciVision Biotech Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 161. SciVision Biotech Recent Developments/Updates
Table 162. SciVision Biotech Competitive Strengths & Weaknesses
Table 163. Prollenium Basic Information, Manufacturing Base and Competitors
Table 164. Prollenium Major Business
Table 165. Prollenium Botulinum Toxin & HA Dermal Filler Product and Services
Table 166. Prollenium Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 167. Prollenium Recent Developments/Updates
Table 168. Prollenium Competitive Strengths & Weaknesses
Table 169. Bohus BioTech Basic Information, Manufacturing Base and Competitors
Table 170. Bohus BioTech Major Business
Table 171. Bohus BioTech Botulinum Toxin & HA Dermal Filler Product and Services
Table 172. Bohus BioTech Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 173. Bohus BioTech Recent Developments/Updates
Table 174. Bohus BioTech Competitive Strengths & Weaknesses
Table 175. Caregen Basic Information, Manufacturing Base and Competitors
Table 176. Caregen Major Business
Table 177. Caregen Botulinum Toxin & HA Dermal Filler Product and Services
Table 178. Caregen Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 179. Caregen Recent Developments/Updates
Table 180. Caregen Competitive Strengths & Weaknesses
Table 181. Ipsen Basic Information, Manufacturing Base and Competitors
Table 182. Ipsen Major Business
Table 183. Ipsen Botulinum Toxin & HA Dermal Filler Product and Services
Table 184. Ipsen Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 185. Ipsen Recent Developments/Updates
Table 186. Ipsen Competitive Strengths & Weaknesses
Table 187. LIBP Basic Information, Manufacturing Base and Competitors
Table 188. LIBP Major Business
Table 189. LIBP Botulinum Toxin & HA Dermal Filler Product and Services
Table 190. LIBP Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 191. LIBP Recent Developments/Updates
Table 192. LIBP Competitive Strengths & Weaknesses
Table 193. US World Meds Basic Information, Manufacturing Base and Competitors
Table 194. US World Meds Major Business
Table 195. US World Meds Botulinum Toxin & HA Dermal Filler Product and Services
Table 196. US World Meds Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 197. US World Meds Recent Developments/Updates
Table 198. US World Meds Competitive Strengths & Weaknesses
Table 199. Daewoong Basic Information, Manufacturing Base and Competitors
Table 200. Daewoong Major Business
Table 201. Daewoong Botulinum Toxin & HA Dermal Filler Product and Services
Table 202. Daewoong Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 203. Daewoong Recent Developments/Updates
Table 204. Daewoong Competitive Strengths & Weaknesses
Table 205. JETEMA Basic Information, Manufacturing Base and Competitors
Table 206. JETEMA Major Business
Table 207. JETEMA Botulinum Toxin & HA Dermal Filler Product and Services
Table 208. JETEMA Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 209. JETEMA Recent Developments/Updates
Table 210. JETEMA Competitive Strengths & Weaknesses
Table 211. Global Key Players of Botulinum Toxin & HA Dermal Filler Upstream (Raw Materials)
Table 212. Global Botulinum Toxin & HA Dermal Filler Typical Customers
Table 213. Botulinum Toxin & HA Dermal Filler Typical Distributors


List of Figures
Figure 1. Botulinum Toxin & HA Dermal Filler Picture
Figure 2. World Botulinum Toxin & HA Dermal Filler Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Botulinum Toxin & HA Dermal Filler Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Botulinum Toxin & HA Dermal Filler Production (2019-2030) & (K Units)
Figure 5. World Botulinum Toxin & HA Dermal Filler Average Price (2019-2030) & (US$/Unit)
Figure 6. World Botulinum Toxin & HA Dermal Filler Production Value Market Share by Region (2019-2030)
Figure 7. World Botulinum Toxin & HA Dermal Filler Production Market Share by Region (2019-2030)
Figure 8. North America Botulinum Toxin & HA Dermal Filler Production (2019-2030) & (K Units)
Figure 9. Europe Botulinum Toxin & HA Dermal Filler Production (2019-2030) & (K Units)
Figure 10. China Botulinum Toxin & HA Dermal Filler Production (2019-2030) & (K Units)
Figure 11. Japan Botulinum Toxin & HA Dermal Filler Production (2019-2030) & (K Units)
Figure 12. Botulinum Toxin & HA Dermal Filler Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Botulinum Toxin & HA Dermal Filler Consumption (2019-2030) & (K Units)
Figure 15. World Botulinum Toxin & HA Dermal Filler Consumption Market Share by Region (2019-2030)
Figure 16. United States Botulinum Toxin & HA Dermal Filler Consumption (2019-2030) & (K Units)
Figure 17. China Botulinum Toxin & HA Dermal Filler Consumption (2019-2030) & (K Units)
Figure 18. Europe Botulinum Toxin & HA Dermal Filler Consumption (2019-2030) & (K Units)
Figure 19. Japan Botulinum Toxin & HA Dermal Filler Consumption (2019-2030) & (K Units)
Figure 20. South Korea Botulinum Toxin & HA Dermal Filler Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Botulinum Toxin & HA Dermal Filler Consumption (2019-2030) & (K Units)
Figure 22. India Botulinum Toxin & HA Dermal Filler Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Botulinum Toxin & HA Dermal Filler by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Botulinum Toxin & HA Dermal Filler Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Botulinum Toxin & HA Dermal Filler Markets in 2023
Figure 26. United States VS China: Botulinum Toxin & HA Dermal Filler Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Botulinum Toxin & HA Dermal Filler Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Botulinum Toxin & HA Dermal Filler Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Market Share 2023
Figure 30. China Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Market Share 2023
Figure 32. World Botulinum Toxin & HA Dermal Filler Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Botulinum Toxin & HA Dermal Filler Production Value Market Share by Type in 2023
Figure 34. Botulinum Toxin
Figure 35. HA Dermal Filler
Figure 36. World Botulinum Toxin & HA Dermal Filler Production Market Share by Type (2019-2030)
Figure 37. World Botulinum Toxin & HA Dermal Filler Production Value Market Share by Type (2019-2030)
Figure 38. World Botulinum Toxin & HA Dermal Filler Average Price by Type (2019-2030) & (US$/Unit)
Figure 39. World Botulinum Toxin & HA Dermal Filler Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Botulinum Toxin & HA Dermal Filler Production Value Market Share by Application in 2023
Figure 41. Medical
Figure 42. Cosmetics
Figure 43. World Botulinum Toxin & HA Dermal Filler Production Market Share by Application (2019-2030)
Figure 44. World Botulinum Toxin & HA Dermal Filler Production Value Market Share by Application (2019-2030)
Figure 45. World Botulinum Toxin & HA Dermal Filler Average Price by Application (2019-2030) & (US$/Unit)
Figure 46. Botulinum Toxin & HA Dermal Filler Industry Chain
Figure 47. Botulinum Toxin & HA Dermal Filler Procurement Model
Figure 48. Botulinum Toxin & HA Dermal Filler Sales Model
Figure 49. Botulinum Toxin & HA Dermal Filler Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

AbbVie
Galderma
LG Life Sciences
Merz
Medytox
Hugel
Croma-Pharma
Beijing IMEIK
Bloomage Bio
Elravie (Humedix)
Cleviel (Pharma Research Products)
Haohai Biological
Teoxane
Sinclair
Suneva Medical
CG Bio
SciVision Biotech
Prollenium
Bohus BioTech
Caregen
Ipsen
LIBP
US World Meds
Daewoong
JETEMA
btl

Related Reports

Global Botulinum Toxin & HA Dermal Filler Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030 xian22

Global Botulinum Toxin & HA Dermal Filler Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 15 Sep 2024

date Pharma & Healthcare

HA Dermal Filler are gel-like substances injected under the skin to restore lost volume, smooth and soften wrinkles or enhance facial contours. HA Dermal Filler have developed rapidly and are getting closer and closer to "perfect" products: long-lasting but non-permanent, high tolerability, exquisite and natural cosmetic effects, and reversible in the event of adverse surgical outcomes. HA Dermal Filler help to diminish facial lines and restore volume and fullness in the face. HA Dermal Filler can be used to: plump thin lips, enhance shallow contours, soften facial creases and wrinkles and improve the appearance of recessed scars. HA Dermal Filler can be very helpful in those with early signs of aging, or as a value-added part of facial rejuvenation surgery.

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Botulinum Toxin & HA Dermal Filler Supply, Demand and Key Producers, 2024-2030

Global Botulinum Toxin & HA Dermal Filler Supply, Demand and Key Producers, 2024-2030

Page: 163

Published Date: 15 Sep 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

HA Dermal Filler are gel-like substances injected under the skin to restore lost volume, smooth and soften wrinkles or enhance facial contours. HA Dermal Filler have developed rapidly and are getting closer and closer to "perfect" products: long-lasting but non-permanent, high tolerability, exquisite and natural cosmetic effects, and reversible in the event of adverse surgical outcomes. HA Dermal Filler help to diminish facial lines and restore volume and fullness in the face. HA Dermal Filler can be used to: plump thin lips, enhance shallow contours, soften facial creases and wrinkles and improve the appearance of recessed scars. HA Dermal Filler can be very helpful in those with early signs of aging, or as a value-added part of facial rejuvenation surgery.

Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.

The global Botulinum Toxin & HA Dermal Filler market size is expected to reach $ 28320 million by 2030, rising at a market growth of 10.0% CAGR during the forecast period (2024-2030).

The HA Dermal Filler and botulinum toxin market is driven by the growing demand for non-invasive cosmetic procedures. As people seek quicker, safer, and more affordable ways to enhance their appearance, the demand for products like botulinum toxin (Botox) and HA Dermal Filler has surged. This trend is further fueled by increasing social media influence, rising disposable incomes, and the aging population looking for anti-aging treatments. The availability of minimally invasive options with shorter recovery times compared to surgical procedures also appeals to a broad demographic, further pushing market growth.

However, the market faces several challenges. One of the key issues is the risk of side effects and complications from improper administration, which can lead to negative public perception. Additionally, the regulatory landscape is stringent, with healthcare authorities enforcing strict safety and efficacy standards. High costs of premium products, as well as the need for repeated treatments to maintain results, may also deter some consumers, limiting the market's potential growth.

Global key players of HA Dermal Filler and botulinum toxin include AbbVie, Galderma, LG Life Sciences, etc. The top five players hold a share about 78%. Americas is the largest market, has a share about 58%, followed by Europe and Asia-Pacific, with share 20% and 18%, separately.

This report studies the global Botulinum Toxin & HA Dermal Filler production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Botulinum Toxin & HA Dermal Filler and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Botulinum Toxin & HA Dermal Filler that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Botulinum Toxin & HA Dermal Filler total production and demand, 2019-2030, (K Units)
Global Botulinum Toxin & HA Dermal Filler total production value, 2019-2030, (USD Million)
Global Botulinum Toxin & HA Dermal Filler production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global Botulinum Toxin & HA Dermal Filler consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Botulinum Toxin & HA Dermal Filler domestic production, consumption, key domestic manufacturers and share
Global Botulinum Toxin & HA Dermal Filler production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Botulinum Toxin & HA Dermal Filler production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Botulinum Toxin & HA Dermal Filler production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global Botulinum Toxin & HA Dermal Filler market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Galderma, LG Life Sciences, Merz, Medytox, Hugel, Croma-Pharma, Beijing IMEIK, Bloomage Bio, Elravie (Humedix), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Botulinum Toxin & HA Dermal Filler market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Botulinum Toxin & HA Dermal Filler Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Botulinum Toxin & HA Dermal Filler Market, Segmentation by Type:
Botulinum Toxin
HA Dermal Filler

Global Botulinum Toxin & HA Dermal Filler Market, Segmentation by Application:
Medical
Cosmetics

Companies Profiled:
AbbVie
Galderma
LG Life Sciences
Merz
Medytox
Hugel
Croma-Pharma
Beijing IMEIK
Bloomage Bio
Elravie (Humedix)
Cleviel (Pharma Research Products)
Haohai Biological
Teoxane
Sinclair
Suneva Medical
CG Bio
SciVision Biotech
Prollenium
Bohus BioTech
Caregen
Ipsen
LIBP
US World Meds
Daewoong
JETEMA

Key Questions Answered:
1. How big is the global Botulinum Toxin & HA Dermal Filler market?
2. What is the demand of the global Botulinum Toxin & HA Dermal Filler market?
3. What is the year over year growth of the global Botulinum Toxin & HA Dermal Filler market?
4. What is the production and production value of the global Botulinum Toxin & HA Dermal Filler market?
5. Who are the key producers in the global Botulinum Toxin & HA Dermal Filler market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Botulinum Toxin & HA Dermal Filler Introduction
1.2 World Botulinum Toxin & HA Dermal Filler Supply & Forecast
1.2.1 World Botulinum Toxin & HA Dermal Filler Production Value (2019 & 2023 & 2030)
1.2.2 World Botulinum Toxin & HA Dermal Filler Production (2019-2030)
1.2.3 World Botulinum Toxin & HA Dermal Filler Pricing Trends (2019-2030)
1.3 World Botulinum Toxin & HA Dermal Filler Production by Region (Based on Production Site)
1.3.1 World Botulinum Toxin & HA Dermal Filler Production Value by Region (2019-2030)
1.3.2 World Botulinum Toxin & HA Dermal Filler Production by Region (2019-2030)
1.3.3 World Botulinum Toxin & HA Dermal Filler Average Price by Region (2019-2030)
1.3.4 North America Botulinum Toxin & HA Dermal Filler Production (2019-2030)
1.3.5 Europe Botulinum Toxin & HA Dermal Filler Production (2019-2030)
1.3.6 China Botulinum Toxin & HA Dermal Filler Production (2019-2030)
1.3.7 Japan Botulinum Toxin & HA Dermal Filler Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Botulinum Toxin & HA Dermal Filler Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Botulinum Toxin & HA Dermal Filler Major Market Trends

2 Demand Summary
2.1 World Botulinum Toxin & HA Dermal Filler Demand (2019-2030)
2.2 World Botulinum Toxin & HA Dermal Filler Consumption by Region
2.2.1 World Botulinum Toxin & HA Dermal Filler Consumption by Region (2019-2024)
2.2.2 World Botulinum Toxin & HA Dermal Filler Consumption Forecast by Region (2025-2030)
2.3 United States Botulinum Toxin & HA Dermal Filler Consumption (2019-2030)
2.4 China Botulinum Toxin & HA Dermal Filler Consumption (2019-2030)
2.5 Europe Botulinum Toxin & HA Dermal Filler Consumption (2019-2030)
2.6 Japan Botulinum Toxin & HA Dermal Filler Consumption (2019-2030)
2.7 South Korea Botulinum Toxin & HA Dermal Filler Consumption (2019-2030)
2.8 ASEAN Botulinum Toxin & HA Dermal Filler Consumption (2019-2030)
2.9 India Botulinum Toxin & HA Dermal Filler Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
3.1 World Botulinum Toxin & HA Dermal Filler Production Value by Manufacturer (2019-2024)
3.2 World Botulinum Toxin & HA Dermal Filler Production by Manufacturer (2019-2024)
3.3 World Botulinum Toxin & HA Dermal Filler Average Price by Manufacturer (2019-2024)
3.4 Botulinum Toxin & HA Dermal Filler Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Botulinum Toxin & HA Dermal Filler Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Botulinum Toxin & HA Dermal Filler in 2023
3.5.3 Global Concentration Ratios (CR8) for Botulinum Toxin & HA Dermal Filler in 2023
3.6 Botulinum Toxin & HA Dermal Filler Market: Overall Company Footprint Analysis
3.6.1 Botulinum Toxin & HA Dermal Filler Market: Region Footprint
3.6.2 Botulinum Toxin & HA Dermal Filler Market: Company Product Type Footprint
3.6.3 Botulinum Toxin & HA Dermal Filler Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Botulinum Toxin & HA Dermal Filler Production Value Comparison
4.1.1 United States VS China: Botulinum Toxin & HA Dermal Filler Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Botulinum Toxin & HA Dermal Filler Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Botulinum Toxin & HA Dermal Filler Production Comparison
4.2.1 United States VS China: Botulinum Toxin & HA Dermal Filler Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Botulinum Toxin & HA Dermal Filler Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Botulinum Toxin & HA Dermal Filler Consumption Comparison
4.3.1 United States VS China: Botulinum Toxin & HA Dermal Filler Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Botulinum Toxin & HA Dermal Filler Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Botulinum Toxin & HA Dermal Filler Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Botulinum Toxin & HA Dermal Filler Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Value (2019-2024)
4.4.3 United States Based Manufacturers Botulinum Toxin & HA Dermal Filler Production (2019-2024)
4.5 China Based Botulinum Toxin & HA Dermal Filler Manufacturers and Market Share
4.5.1 China Based Botulinum Toxin & HA Dermal Filler Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Value (2019-2024)
4.5.3 China Based Manufacturers Botulinum Toxin & HA Dermal Filler Production (2019-2024)
4.6 Rest of World Based Botulinum Toxin & HA Dermal Filler Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Botulinum Toxin & HA Dermal Filler Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Botulinum Toxin & HA Dermal Filler Production (2019-2024)

5 Market Analysis by Type
5.1 World Botulinum Toxin & HA Dermal Filler Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Botulinum Toxin
5.2.2 HA Dermal Filler
5.3 Market Segment by Type
5.3.1 World Botulinum Toxin & HA Dermal Filler Production by Type (2019-2030)
5.3.2 World Botulinum Toxin & HA Dermal Filler Production Value by Type (2019-2030)
5.3.3 World Botulinum Toxin & HA Dermal Filler Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Botulinum Toxin & HA Dermal Filler Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Medical
6.2.2 Cosmetics
6.3 Market Segment by Application
6.3.1 World Botulinum Toxin & HA Dermal Filler Production by Application (2019-2030)
6.3.2 World Botulinum Toxin & HA Dermal Filler Production Value by Application (2019-2030)
6.3.3 World Botulinum Toxin & HA Dermal Filler Average Price by Application (2019-2030)

7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Details
7.1.2 AbbVie Major Business
7.1.3 AbbVie Botulinum Toxin & HA Dermal Filler Product and Services
7.1.4 AbbVie Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 AbbVie Recent Developments/Updates
7.1.6 AbbVie Competitive Strengths & Weaknesses
7.2 Galderma
7.2.1 Galderma Details
7.2.2 Galderma Major Business
7.2.3 Galderma Botulinum Toxin & HA Dermal Filler Product and Services
7.2.4 Galderma Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Galderma Recent Developments/Updates
7.2.6 Galderma Competitive Strengths & Weaknesses
7.3 LG Life Sciences
7.3.1 LG Life Sciences Details
7.3.2 LG Life Sciences Major Business
7.3.3 LG Life Sciences Botulinum Toxin & HA Dermal Filler Product and Services
7.3.4 LG Life Sciences Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 LG Life Sciences Recent Developments/Updates
7.3.6 LG Life Sciences Competitive Strengths & Weaknesses
7.4 Merz
7.4.1 Merz Details
7.4.2 Merz Major Business
7.4.3 Merz Botulinum Toxin & HA Dermal Filler Product and Services
7.4.4 Merz Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Merz Recent Developments/Updates
7.4.6 Merz Competitive Strengths & Weaknesses
7.5 Medytox
7.5.1 Medytox Details
7.5.2 Medytox Major Business
7.5.3 Medytox Botulinum Toxin & HA Dermal Filler Product and Services
7.5.4 Medytox Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Medytox Recent Developments/Updates
7.5.6 Medytox Competitive Strengths & Weaknesses
7.6 Hugel
7.6.1 Hugel Details
7.6.2 Hugel Major Business
7.6.3 Hugel Botulinum Toxin & HA Dermal Filler Product and Services
7.6.4 Hugel Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Hugel Recent Developments/Updates
7.6.6 Hugel Competitive Strengths & Weaknesses
7.7 Croma-Pharma
7.7.1 Croma-Pharma Details
7.7.2 Croma-Pharma Major Business
7.7.3 Croma-Pharma Botulinum Toxin & HA Dermal Filler Product and Services
7.7.4 Croma-Pharma Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Croma-Pharma Recent Developments/Updates
7.7.6 Croma-Pharma Competitive Strengths & Weaknesses
7.8 Beijing IMEIK
7.8.1 Beijing IMEIK Details
7.8.2 Beijing IMEIK Major Business
7.8.3 Beijing IMEIK Botulinum Toxin & HA Dermal Filler Product and Services
7.8.4 Beijing IMEIK Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Beijing IMEIK Recent Developments/Updates
7.8.6 Beijing IMEIK Competitive Strengths & Weaknesses
7.9 Bloomage Bio
7.9.1 Bloomage Bio Details
7.9.2 Bloomage Bio Major Business
7.9.3 Bloomage Bio Botulinum Toxin & HA Dermal Filler Product and Services
7.9.4 Bloomage Bio Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Bloomage Bio Recent Developments/Updates
7.9.6 Bloomage Bio Competitive Strengths & Weaknesses
7.10 Elravie (Humedix)
7.10.1 Elravie (Humedix) Details
7.10.2 Elravie (Humedix) Major Business
7.10.3 Elravie (Humedix) Botulinum Toxin & HA Dermal Filler Product and Services
7.10.4 Elravie (Humedix) Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Elravie (Humedix) Recent Developments/Updates
7.10.6 Elravie (Humedix) Competitive Strengths & Weaknesses
7.11 Cleviel (Pharma Research Products)
7.11.1 Cleviel (Pharma Research Products) Details
7.11.2 Cleviel (Pharma Research Products) Major Business
7.11.3 Cleviel (Pharma Research Products) Botulinum Toxin & HA Dermal Filler Product and Services
7.11.4 Cleviel (Pharma Research Products) Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Cleviel (Pharma Research Products) Recent Developments/Updates
7.11.6 Cleviel (Pharma Research Products) Competitive Strengths & Weaknesses
7.12 Haohai Biological
7.12.1 Haohai Biological Details
7.12.2 Haohai Biological Major Business
7.12.3 Haohai Biological Botulinum Toxin & HA Dermal Filler Product and Services
7.12.4 Haohai Biological Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Haohai Biological Recent Developments/Updates
7.12.6 Haohai Biological Competitive Strengths & Weaknesses
7.13 Teoxane
7.13.1 Teoxane Details
7.13.2 Teoxane Major Business
7.13.3 Teoxane Botulinum Toxin & HA Dermal Filler Product and Services
7.13.4 Teoxane Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Teoxane Recent Developments/Updates
7.13.6 Teoxane Competitive Strengths & Weaknesses
7.14 Sinclair
7.14.1 Sinclair Details
7.14.2 Sinclair Major Business
7.14.3 Sinclair Botulinum Toxin & HA Dermal Filler Product and Services
7.14.4 Sinclair Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Sinclair Recent Developments/Updates
7.14.6 Sinclair Competitive Strengths & Weaknesses
7.15 Suneva Medical
7.15.1 Suneva Medical Details
7.15.2 Suneva Medical Major Business
7.15.3 Suneva Medical Botulinum Toxin & HA Dermal Filler Product and Services
7.15.4 Suneva Medical Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Suneva Medical Recent Developments/Updates
7.15.6 Suneva Medical Competitive Strengths & Weaknesses
7.16 CG Bio
7.16.1 CG Bio Details
7.16.2 CG Bio Major Business
7.16.3 CG Bio Botulinum Toxin & HA Dermal Filler Product and Services
7.16.4 CG Bio Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 CG Bio Recent Developments/Updates
7.16.6 CG Bio Competitive Strengths & Weaknesses
7.17 SciVision Biotech
7.17.1 SciVision Biotech Details
7.17.2 SciVision Biotech Major Business
7.17.3 SciVision Biotech Botulinum Toxin & HA Dermal Filler Product and Services
7.17.4 SciVision Biotech Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 SciVision Biotech Recent Developments/Updates
7.17.6 SciVision Biotech Competitive Strengths & Weaknesses
7.18 Prollenium
7.18.1 Prollenium Details
7.18.2 Prollenium Major Business
7.18.3 Prollenium Botulinum Toxin & HA Dermal Filler Product and Services
7.18.4 Prollenium Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.18.5 Prollenium Recent Developments/Updates
7.18.6 Prollenium Competitive Strengths & Weaknesses
7.19 Bohus BioTech
7.19.1 Bohus BioTech Details
7.19.2 Bohus BioTech Major Business
7.19.3 Bohus BioTech Botulinum Toxin & HA Dermal Filler Product and Services
7.19.4 Bohus BioTech Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.19.5 Bohus BioTech Recent Developments/Updates
7.19.6 Bohus BioTech Competitive Strengths & Weaknesses
7.20 Caregen
7.20.1 Caregen Details
7.20.2 Caregen Major Business
7.20.3 Caregen Botulinum Toxin & HA Dermal Filler Product and Services
7.20.4 Caregen Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.20.5 Caregen Recent Developments/Updates
7.20.6 Caregen Competitive Strengths & Weaknesses
7.21 Ipsen
7.21.1 Ipsen Details
7.21.2 Ipsen Major Business
7.21.3 Ipsen Botulinum Toxin & HA Dermal Filler Product and Services
7.21.4 Ipsen Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.21.5 Ipsen Recent Developments/Updates
7.21.6 Ipsen Competitive Strengths & Weaknesses
7.22 LIBP
7.22.1 LIBP Details
7.22.2 LIBP Major Business
7.22.3 LIBP Botulinum Toxin & HA Dermal Filler Product and Services
7.22.4 LIBP Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.22.5 LIBP Recent Developments/Updates
7.22.6 LIBP Competitive Strengths & Weaknesses
7.23 US World Meds
7.23.1 US World Meds Details
7.23.2 US World Meds Major Business
7.23.3 US World Meds Botulinum Toxin & HA Dermal Filler Product and Services
7.23.4 US World Meds Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.23.5 US World Meds Recent Developments/Updates
7.23.6 US World Meds Competitive Strengths & Weaknesses
7.24 Daewoong
7.24.1 Daewoong Details
7.24.2 Daewoong Major Business
7.24.3 Daewoong Botulinum Toxin & HA Dermal Filler Product and Services
7.24.4 Daewoong Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.24.5 Daewoong Recent Developments/Updates
7.24.6 Daewoong Competitive Strengths & Weaknesses
7.25 JETEMA
7.25.1 JETEMA Details
7.25.2 JETEMA Major Business
7.25.3 JETEMA Botulinum Toxin & HA Dermal Filler Product and Services
7.25.4 JETEMA Botulinum Toxin & HA Dermal Filler Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.25.5 JETEMA Recent Developments/Updates
7.25.6 JETEMA Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Botulinum Toxin & HA Dermal Filler Industry Chain
8.2 Botulinum Toxin & HA Dermal Filler Upstream Analysis
8.2.1 Botulinum Toxin & HA Dermal Filler Core Raw Materials
8.2.2 Main Manufacturers of Botulinum Toxin & HA Dermal Filler Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Botulinum Toxin & HA Dermal Filler Production Mode
8.6 Botulinum Toxin & HA Dermal Filler Procurement Model
8.7 Botulinum Toxin & HA Dermal Filler Industry Sales Model and Sales Channels
8.7.1 Botulinum Toxin & HA Dermal Filler Sales Model
8.7.2 Botulinum Toxin & HA Dermal Filler Typical Distributors

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Botulinum Toxin & HA Dermal Filler Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Botulinum Toxin & HA Dermal Filler Production Value by Region (2019-2024) & (USD Million)
Table 3. World Botulinum Toxin & HA Dermal Filler Production Value by Region (2025-2030) & (USD Million)
Table 4. World Botulinum Toxin & HA Dermal Filler Production Value Market Share by Region (2019-2024)
Table 5. World Botulinum Toxin & HA Dermal Filler Production Value Market Share by Region (2025-2030)
Table 6. World Botulinum Toxin & HA Dermal Filler Production by Region (2019-2024) & (K Units)
Table 7. World Botulinum Toxin & HA Dermal Filler Production by Region (2025-2030) & (K Units)
Table 8. World Botulinum Toxin & HA Dermal Filler Production Market Share by Region (2019-2024)
Table 9. World Botulinum Toxin & HA Dermal Filler Production Market Share by Region (2025-2030)
Table 10. World Botulinum Toxin & HA Dermal Filler Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Botulinum Toxin & HA Dermal Filler Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Botulinum Toxin & HA Dermal Filler Major Market Trends
Table 13. World Botulinum Toxin & HA Dermal Filler Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Botulinum Toxin & HA Dermal Filler Consumption by Region (2019-2024) & (K Units)
Table 15. World Botulinum Toxin & HA Dermal Filler Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Botulinum Toxin & HA Dermal Filler Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Botulinum Toxin & HA Dermal Filler Producers in 2023
Table 18. World Botulinum Toxin & HA Dermal Filler Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Botulinum Toxin & HA Dermal Filler Producers in 2023
Table 20. World Botulinum Toxin & HA Dermal Filler Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Botulinum Toxin & HA Dermal Filler Company Evaluation Quadrant
Table 22. World Botulinum Toxin & HA Dermal Filler Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Botulinum Toxin & HA Dermal Filler Production Site of Key Manufacturer
Table 24. Botulinum Toxin & HA Dermal Filler Market: Company Product Type Footprint
Table 25. Botulinum Toxin & HA Dermal Filler Market: Company Product Application Footprint
Table 26. Botulinum Toxin & HA Dermal Filler Competitive Factors
Table 27. Botulinum Toxin & HA Dermal Filler New Entrant and Capacity Expansion Plans
Table 28. Botulinum Toxin & HA Dermal Filler Mergers & Acquisitions Activity
Table 29. United States VS China Botulinum Toxin & HA Dermal Filler Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Botulinum Toxin & HA Dermal Filler Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Botulinum Toxin & HA Dermal Filler Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Botulinum Toxin & HA Dermal Filler Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Botulinum Toxin & HA Dermal Filler Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Market Share (2019-2024)
Table 37. China Based Botulinum Toxin & HA Dermal Filler Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Botulinum Toxin & HA Dermal Filler Production, (2019-2024) & (K Units)
Table 41. China Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Market Share (2019-2024)
Table 42. Rest of World Based Botulinum Toxin & HA Dermal Filler Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Botulinum Toxin & HA Dermal Filler Production, (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Market Share (2019-2024)
Table 47. World Botulinum Toxin & HA Dermal Filler Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Botulinum Toxin & HA Dermal Filler Production by Type (2019-2024) & (K Units)
Table 49. World Botulinum Toxin & HA Dermal Filler Production by Type (2025-2030) & (K Units)
Table 50. World Botulinum Toxin & HA Dermal Filler Production Value by Type (2019-2024) & (USD Million)
Table 51. World Botulinum Toxin & HA Dermal Filler Production Value by Type (2025-2030) & (USD Million)
Table 52. World Botulinum Toxin & HA Dermal Filler Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Botulinum Toxin & HA Dermal Filler Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Botulinum Toxin & HA Dermal Filler Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Botulinum Toxin & HA Dermal Filler Production by Application (2019-2024) & (K Units)
Table 56. World Botulinum Toxin & HA Dermal Filler Production by Application (2025-2030) & (K Units)
Table 57. World Botulinum Toxin & HA Dermal Filler Production Value by Application (2019-2024) & (USD Million)
Table 58. World Botulinum Toxin & HA Dermal Filler Production Value by Application (2025-2030) & (USD Million)
Table 59. World Botulinum Toxin & HA Dermal Filler Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Botulinum Toxin & HA Dermal Filler Average Price by Application (2025-2030) & (US$/Unit)
Table 61. AbbVie Basic Information, Manufacturing Base and Competitors
Table 62. AbbVie Major Business
Table 63. AbbVie Botulinum Toxin & HA Dermal Filler Product and Services
Table 64. AbbVie Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. AbbVie Recent Developments/Updates
Table 66. AbbVie Competitive Strengths & Weaknesses
Table 67. Galderma Basic Information, Manufacturing Base and Competitors
Table 68. Galderma Major Business
Table 69. Galderma Botulinum Toxin & HA Dermal Filler Product and Services
Table 70. Galderma Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Galderma Recent Developments/Updates
Table 72. Galderma Competitive Strengths & Weaknesses
Table 73. LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 74. LG Life Sciences Major Business
Table 75. LG Life Sciences Botulinum Toxin & HA Dermal Filler Product and Services
Table 76. LG Life Sciences Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. LG Life Sciences Recent Developments/Updates
Table 78. LG Life Sciences Competitive Strengths & Weaknesses
Table 79. Merz Basic Information, Manufacturing Base and Competitors
Table 80. Merz Major Business
Table 81. Merz Botulinum Toxin & HA Dermal Filler Product and Services
Table 82. Merz Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Merz Recent Developments/Updates
Table 84. Merz Competitive Strengths & Weaknesses
Table 85. Medytox Basic Information, Manufacturing Base and Competitors
Table 86. Medytox Major Business
Table 87. Medytox Botulinum Toxin & HA Dermal Filler Product and Services
Table 88. Medytox Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Medytox Recent Developments/Updates
Table 90. Medytox Competitive Strengths & Weaknesses
Table 91. Hugel Basic Information, Manufacturing Base and Competitors
Table 92. Hugel Major Business
Table 93. Hugel Botulinum Toxin & HA Dermal Filler Product and Services
Table 94. Hugel Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Hugel Recent Developments/Updates
Table 96. Hugel Competitive Strengths & Weaknesses
Table 97. Croma-Pharma Basic Information, Manufacturing Base and Competitors
Table 98. Croma-Pharma Major Business
Table 99. Croma-Pharma Botulinum Toxin & HA Dermal Filler Product and Services
Table 100. Croma-Pharma Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Croma-Pharma Recent Developments/Updates
Table 102. Croma-Pharma Competitive Strengths & Weaknesses
Table 103. Beijing IMEIK Basic Information, Manufacturing Base and Competitors
Table 104. Beijing IMEIK Major Business
Table 105. Beijing IMEIK Botulinum Toxin & HA Dermal Filler Product and Services
Table 106. Beijing IMEIK Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Beijing IMEIK Recent Developments/Updates
Table 108. Beijing IMEIK Competitive Strengths & Weaknesses
Table 109. Bloomage Bio Basic Information, Manufacturing Base and Competitors
Table 110. Bloomage Bio Major Business
Table 111. Bloomage Bio Botulinum Toxin & HA Dermal Filler Product and Services
Table 112. Bloomage Bio Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Bloomage Bio Recent Developments/Updates
Table 114. Bloomage Bio Competitive Strengths & Weaknesses
Table 115. Elravie (Humedix) Basic Information, Manufacturing Base and Competitors
Table 116. Elravie (Humedix) Major Business
Table 117. Elravie (Humedix) Botulinum Toxin & HA Dermal Filler Product and Services
Table 118. Elravie (Humedix) Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Elravie (Humedix) Recent Developments/Updates
Table 120. Elravie (Humedix) Competitive Strengths & Weaknesses
Table 121. Cleviel (Pharma Research Products) Basic Information, Manufacturing Base and Competitors
Table 122. Cleviel (Pharma Research Products) Major Business
Table 123. Cleviel (Pharma Research Products) Botulinum Toxin & HA Dermal Filler Product and Services
Table 124. Cleviel (Pharma Research Products) Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Cleviel (Pharma Research Products) Recent Developments/Updates
Table 126. Cleviel (Pharma Research Products) Competitive Strengths & Weaknesses
Table 127. Haohai Biological Basic Information, Manufacturing Base and Competitors
Table 128. Haohai Biological Major Business
Table 129. Haohai Biological Botulinum Toxin & HA Dermal Filler Product and Services
Table 130. Haohai Biological Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Haohai Biological Recent Developments/Updates
Table 132. Haohai Biological Competitive Strengths & Weaknesses
Table 133. Teoxane Basic Information, Manufacturing Base and Competitors
Table 134. Teoxane Major Business
Table 135. Teoxane Botulinum Toxin & HA Dermal Filler Product and Services
Table 136. Teoxane Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Teoxane Recent Developments/Updates
Table 138. Teoxane Competitive Strengths & Weaknesses
Table 139. Sinclair Basic Information, Manufacturing Base and Competitors
Table 140. Sinclair Major Business
Table 141. Sinclair Botulinum Toxin & HA Dermal Filler Product and Services
Table 142. Sinclair Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Sinclair Recent Developments/Updates
Table 144. Sinclair Competitive Strengths & Weaknesses
Table 145. Suneva Medical Basic Information, Manufacturing Base and Competitors
Table 146. Suneva Medical Major Business
Table 147. Suneva Medical Botulinum Toxin & HA Dermal Filler Product and Services
Table 148. Suneva Medical Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Suneva Medical Recent Developments/Updates
Table 150. Suneva Medical Competitive Strengths & Weaknesses
Table 151. CG Bio Basic Information, Manufacturing Base and Competitors
Table 152. CG Bio Major Business
Table 153. CG Bio Botulinum Toxin & HA Dermal Filler Product and Services
Table 154. CG Bio Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 155. CG Bio Recent Developments/Updates
Table 156. CG Bio Competitive Strengths & Weaknesses
Table 157. SciVision Biotech Basic Information, Manufacturing Base and Competitors
Table 158. SciVision Biotech Major Business
Table 159. SciVision Biotech Botulinum Toxin & HA Dermal Filler Product and Services
Table 160. SciVision Biotech Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 161. SciVision Biotech Recent Developments/Updates
Table 162. SciVision Biotech Competitive Strengths & Weaknesses
Table 163. Prollenium Basic Information, Manufacturing Base and Competitors
Table 164. Prollenium Major Business
Table 165. Prollenium Botulinum Toxin & HA Dermal Filler Product and Services
Table 166. Prollenium Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 167. Prollenium Recent Developments/Updates
Table 168. Prollenium Competitive Strengths & Weaknesses
Table 169. Bohus BioTech Basic Information, Manufacturing Base and Competitors
Table 170. Bohus BioTech Major Business
Table 171. Bohus BioTech Botulinum Toxin & HA Dermal Filler Product and Services
Table 172. Bohus BioTech Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 173. Bohus BioTech Recent Developments/Updates
Table 174. Bohus BioTech Competitive Strengths & Weaknesses
Table 175. Caregen Basic Information, Manufacturing Base and Competitors
Table 176. Caregen Major Business
Table 177. Caregen Botulinum Toxin & HA Dermal Filler Product and Services
Table 178. Caregen Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 179. Caregen Recent Developments/Updates
Table 180. Caregen Competitive Strengths & Weaknesses
Table 181. Ipsen Basic Information, Manufacturing Base and Competitors
Table 182. Ipsen Major Business
Table 183. Ipsen Botulinum Toxin & HA Dermal Filler Product and Services
Table 184. Ipsen Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 185. Ipsen Recent Developments/Updates
Table 186. Ipsen Competitive Strengths & Weaknesses
Table 187. LIBP Basic Information, Manufacturing Base and Competitors
Table 188. LIBP Major Business
Table 189. LIBP Botulinum Toxin & HA Dermal Filler Product and Services
Table 190. LIBP Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 191. LIBP Recent Developments/Updates
Table 192. LIBP Competitive Strengths & Weaknesses
Table 193. US World Meds Basic Information, Manufacturing Base and Competitors
Table 194. US World Meds Major Business
Table 195. US World Meds Botulinum Toxin & HA Dermal Filler Product and Services
Table 196. US World Meds Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 197. US World Meds Recent Developments/Updates
Table 198. US World Meds Competitive Strengths & Weaknesses
Table 199. Daewoong Basic Information, Manufacturing Base and Competitors
Table 200. Daewoong Major Business
Table 201. Daewoong Botulinum Toxin & HA Dermal Filler Product and Services
Table 202. Daewoong Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 203. Daewoong Recent Developments/Updates
Table 204. Daewoong Competitive Strengths & Weaknesses
Table 205. JETEMA Basic Information, Manufacturing Base and Competitors
Table 206. JETEMA Major Business
Table 207. JETEMA Botulinum Toxin & HA Dermal Filler Product and Services
Table 208. JETEMA Botulinum Toxin & HA Dermal Filler Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 209. JETEMA Recent Developments/Updates
Table 210. JETEMA Competitive Strengths & Weaknesses
Table 211. Global Key Players of Botulinum Toxin & HA Dermal Filler Upstream (Raw Materials)
Table 212. Global Botulinum Toxin & HA Dermal Filler Typical Customers
Table 213. Botulinum Toxin & HA Dermal Filler Typical Distributors


List of Figures
Figure 1. Botulinum Toxin & HA Dermal Filler Picture
Figure 2. World Botulinum Toxin & HA Dermal Filler Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Botulinum Toxin & HA Dermal Filler Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Botulinum Toxin & HA Dermal Filler Production (2019-2030) & (K Units)
Figure 5. World Botulinum Toxin & HA Dermal Filler Average Price (2019-2030) & (US$/Unit)
Figure 6. World Botulinum Toxin & HA Dermal Filler Production Value Market Share by Region (2019-2030)
Figure 7. World Botulinum Toxin & HA Dermal Filler Production Market Share by Region (2019-2030)
Figure 8. North America Botulinum Toxin & HA Dermal Filler Production (2019-2030) & (K Units)
Figure 9. Europe Botulinum Toxin & HA Dermal Filler Production (2019-2030) & (K Units)
Figure 10. China Botulinum Toxin & HA Dermal Filler Production (2019-2030) & (K Units)
Figure 11. Japan Botulinum Toxin & HA Dermal Filler Production (2019-2030) & (K Units)
Figure 12. Botulinum Toxin & HA Dermal Filler Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Botulinum Toxin & HA Dermal Filler Consumption (2019-2030) & (K Units)
Figure 15. World Botulinum Toxin & HA Dermal Filler Consumption Market Share by Region (2019-2030)
Figure 16. United States Botulinum Toxin & HA Dermal Filler Consumption (2019-2030) & (K Units)
Figure 17. China Botulinum Toxin & HA Dermal Filler Consumption (2019-2030) & (K Units)
Figure 18. Europe Botulinum Toxin & HA Dermal Filler Consumption (2019-2030) & (K Units)
Figure 19. Japan Botulinum Toxin & HA Dermal Filler Consumption (2019-2030) & (K Units)
Figure 20. South Korea Botulinum Toxin & HA Dermal Filler Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Botulinum Toxin & HA Dermal Filler Consumption (2019-2030) & (K Units)
Figure 22. India Botulinum Toxin & HA Dermal Filler Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Botulinum Toxin & HA Dermal Filler by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Botulinum Toxin & HA Dermal Filler Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Botulinum Toxin & HA Dermal Filler Markets in 2023
Figure 26. United States VS China: Botulinum Toxin & HA Dermal Filler Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Botulinum Toxin & HA Dermal Filler Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Botulinum Toxin & HA Dermal Filler Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Market Share 2023
Figure 30. China Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Botulinum Toxin & HA Dermal Filler Production Market Share 2023
Figure 32. World Botulinum Toxin & HA Dermal Filler Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Botulinum Toxin & HA Dermal Filler Production Value Market Share by Type in 2023
Figure 34. Botulinum Toxin
Figure 35. HA Dermal Filler
Figure 36. World Botulinum Toxin & HA Dermal Filler Production Market Share by Type (2019-2030)
Figure 37. World Botulinum Toxin & HA Dermal Filler Production Value Market Share by Type (2019-2030)
Figure 38. World Botulinum Toxin & HA Dermal Filler Average Price by Type (2019-2030) & (US$/Unit)
Figure 39. World Botulinum Toxin & HA Dermal Filler Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Botulinum Toxin & HA Dermal Filler Production Value Market Share by Application in 2023
Figure 41. Medical
Figure 42. Cosmetics
Figure 43. World Botulinum Toxin & HA Dermal Filler Production Market Share by Application (2019-2030)
Figure 44. World Botulinum Toxin & HA Dermal Filler Production Value Market Share by Application (2019-2030)
Figure 45. World Botulinum Toxin & HA Dermal Filler Average Price by Application (2019-2030) & (US$/Unit)
Figure 46. Botulinum Toxin & HA Dermal Filler Industry Chain
Figure 47. Botulinum Toxin & HA Dermal Filler Procurement Model
Figure 48. Botulinum Toxin & HA Dermal Filler Sales Model
Figure 49. Botulinum Toxin & HA Dermal Filler Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

AbbVie
Galderma
LG Life Sciences
Merz
Medytox
Hugel
Croma-Pharma
Beijing IMEIK
Bloomage Bio
Elravie (Humedix)
Cleviel (Pharma Research Products)
Haohai Biological
Teoxane
Sinclair
Suneva Medical
CG Bio
SciVision Biotech
Prollenium
Bohus BioTech
Caregen
Ipsen
LIBP
US World Meds
Daewoong
JETEMA
btl

Related Reports

Global Botulinum Toxin & HA Dermal Filler Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030 xian22
q3

Global Botulinum Toxin & HA Dermal Filler Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

industry 15 Sep 2024

industry Pharma & Healthcare

HA Dermal Filler are gel-like substances injected under the skin to restore lost volume, smooth and soften wrinkles or enhance facial contours. HA Dermal Filler have developed rapidly and are getting closer and closer to "perfect" products: long-lasting but non-permanent, high tolerability, exquisite and natural cosmetic effects, and reversible in the event of adverse surgical outcomes. HA Dermal Filler help to diminish facial lines and restore volume and fullness in the face. HA Dermal Filler can be used to: plump thin lips, enhance shallow contours, soften facial creases and wrinkles and improve the appearance of recessed scars. HA Dermal Filler can be very helpful in those with early signs of aging, or as a value-added part of facial rejuvenation surgery.

jiaGou

Add To Cart

gouMai

Buy Now